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ish Oil and Prevention of
trial Fibrillation*
ariush Mozaffarian, MD, DRPH, FACC
oston, Massachusetts
substantial body of evidence, including findings from
xperiments, observational studies, and clinical trials, indi-
ates that consumption of fish or fish oil reduces the
ncidence of fatal ventricular arrhythmias, manifested as
oronary death or sudden death (1). It is of growing interest
hether fish or fish oil consumption might influence atrial
rrhythmias, particularly atrial fibrillation (AF), which is the
ost common cardiac arrhythmia and afflicts more than 2.2
illion Americans (2). The incidence of AF increases
ramatically with age—lifetime risk after age 40 is 1 in
—and results in fatigue, reduced exercise tolerance, and
ncreased risk and severity of stroke (2). Once AF has
eveloped, anticoagulation reduces stroke risk (although
ith attendant bleeding risks), but other treatment options
re limited. Thus, prevention of AF should be the para-
ount goal.
See page 1505
In this issue of the Journal, Sarrazin et al. (3) have
valuated the effect of fish oil in a canine model of vagally
nduced AF. Adult dogs were fed regular chow or chow plus
sh oil (1.2 g/day, containing 480 mg/day of eicosapenta-
noic acid  docosahexaenoic acid) for 14 days. Atrial
brillation was induced by both extra stimulus (premature
trial complex [PAC]) and burst-pacing techniques. In the
sh-oil-fed dogs, the risk of sustained AF was 70% to
0% lower for PAC-induced AF and 42% lower for burst-
acing-induced AF (p  0.05 for each comparison).
Myocardial biopsies revealed a 100% rise in atrial n-3
atty acid levels and 50% reductions in atrial connexin
evels with fish oil consumption. In a substudy, control dogs
ith inducible AF were re-evaluated after intravenous
nfusion of fish oil (1.4 g); induction of sustained AF by
ACs was less frequent than before the infusion.
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Department of Medicine, Brigham and Women’s Hospital and HarvardI
edical School, and Department of Epidemiology, Harvard School of Public Health,
oston, Massachusetts.Several strengths are evident. An experimental design
enerally minimizes confounding from other known or
nknown risk factors. The dogs were otherwise healthy and
ed reasonable doses of fish oil, providing a relatively
nperturbed biologic model. Controlled vagal stimulation,
lectrophysiological induction of AF, and anesthesia limited
he pathways influencing the risk of AF, allowing evaluation
f a relatively direct (rather than indirect) effect of fish oil on
he heart (e.g., it is unlikely that findings could be explained
y effects of fish oil on autonomic tone, vascular resistance,
r endothelial function). Myocardial biopsies provided di-
ect confirmation of the effects of fish oil on atrial n-3 fatty
cid content and connexin levels.
Limitations are also present. The fish oil treatments were
either randomized nor blinded, raising the possibility of
ias due to differences in the experimental groups or in the
nvestigators’ induction or ascertainment of AF. The intra-
enous substudy lacked an appropriate control group, as
ogs with inducible AF in the first attempt were simply
e-examined after an intravenous infusion (the less common
ccurrence of AF during the second attempt might have
een seen in any group of dogs in whom AF was inducible
n a first attempt, reflecting a type of regression toward the
ean). More meticulous consideration of such issues in
pidemiologic design would have enhanced the study. Also,
f course, the generalizability of these findings to sponta-
eously occurring AF in humans is unclear.
Atrial fibrillation represents a final clinical manifestation
f multiple and likely relatively distinct pathoetiologic
nfluences, from adrenergic and vagal activity in athletes and
ounger adults to reduced myocardial compliance and ven-
ricular dysfunction in older adults. This heterogeneity
uggests that risk factors and effective treatments will likely
ary depending on the specific characteristics and predom-
nant pathoetiologies of AF in the population (e.g., com-
aring younger vs. older adults, spontaneous vs. postopera-
ive AF, or primary prevention vs. restoration of sinus
hythm vs. prevention of recurrence). These issues must be
arefully considered when weighing the generalizability and
mplications of different investigations, and this heteroge-
eity may account for the conflicting results of prior (and
ikely future) studies of fish or fish oil and AF.
In a prospective observational study among older adults,
onsumption of tuna or other broiled or baked fish was
ssociated with a 35% lower incidence of AF (p  0.001),
fter adjustment for other risk factors (4). In contrast, 2
ubsequent observational studies did not find inverse asso-
iations between fish consumption and AF incidence (5,6).
onversely, in an open-label randomized trial among 160
atients undergoing cardiac surgery, perioperative fish oil
reatment (2 g/day) reduced the occurrence of postoperative
F from 33.3% to 15.2% (p  0.01) (7). The clinical
eterogeneity of AF suggests that the major mechanisms for
F prevention by fish oil may vary in different populations.
n the postoperative setting, mechanisms that produce
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Editorial Comment October 9, 2007:1513–4elatively acute benefits may predominate, such as possible
ffects of fish oil on postischemic recovery (8), left ventric-
lar filling (9), vagal activity (10), or atrial electrophysiology
e.g., due to effects on myocardial ion channels [11] or
onnexins [3,12]). For the AF seen with aging, mechanisms
hat produce longer-term benefits may be more important,
uch as effects of fish oil on blood pressure (13), systemic
ascular resistance (14,15) and reactivity (16,17), and endo-
helial activation (18), which might mitigate long-term
entricular (and atrial) remodeling and augment myocardial
ompliance.
Sarrazin et al. (3) have added an important new piece to
his puzzle. In addition to demonstrating clear anti-AF
ffects of fish oil in a controlled experiment, the effects of
sh oil consumption on connexin levels and the relations of
hese differences with inducibility of AF are particularly
ntriguing. In vitro, n-3 fatty acids affect connexins, improv-
ng the functional distribution of cell interface connexins in
ultured rat astrocytes (19) and suppressing hypoxia-
eperfusion-induced phosphorylation of connexin 43 in
ultured human endothelial cells (12). The present findings
onfirm in vivo that fish oil consumption affects connexins
nd suggest a novel potential mechanism for the antiar-
hythmic effects of n-3 fatty acids that should stimulate
urther research in this field. The positive results of the
bservational study (4) and open-label trial (7), together
ith the present findings from Sarrazin et al. (3), paint a
antalizing picture that a simple, low-risk, and low-cost
ietary intervention could reduce the incidence of AF, the
ost common complication of cardiac surgery and the most
ommon cardiac arrhythmia in the general population.
eprint requests and correspondence: Dr. Dariush Mozaffarian,
65 Huntington Avenue, Building 2-319, Boston, Massachusetts
2115. E-mail: dmozaffa@hsph.harvard.edu.
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